Acoustic attenuation by contrast agent microbubbles in superficial tissue markedly diminishes petechiae bioeffects in deep tissue

Investigative Radiology

Volumn 43, Issue 5, 2008, Pages 322-329

  Song, Ji ^a   Klibanov, Alexander L ^b   Hossack, John A ^a   Price, Richard J ^a  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Bioeffects; Contrast media; Microbubbles; Microcirculation; Ultrasound

Indexed keywords

CONTRAST MEDIUM;

ACOUSTICS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; MICROBUBBLE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; ULTRASOUND;

EID: 42449138827     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318168c715     Document Type: Article

References (40)

1. Hom BK, Shrestha R, Palmer SL, et al. Prospective evaluation of vascular complications after liver transplantation: comparison of conventional and microbubble contrast-enhanced ultrasound. Radiology. 2006;241:267-274.
2. Dai Y, Chen MH, Yin SS, et al. Focal liver lesions: can Sonovue-enhanced ultrasound be used to differentiate malignant from benign lesions? Invest Radiol. 2007;42:596-603.
3. Watanabe R, Matsumura M, Munemasa T, et al. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in the liver. Invest Radiol. 2007;42:643-651.
4. Weber MA, Krix M, Jappe U, et al. Pathologic skeletal muscle perfusion in patients with myositis: detection with quantitative contrast-enhanced US - initial results. Radiology. 2005;238:640-649.
5. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998;97:473-483.
6. Bekeredjian R, Chen S, Frenkel PA, et al. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation. 2003;108:1022-1026.
7. Kondo I, Ohmori K, Oshita A, et al. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction. J Am Coll Cardiol. 2004;44:644-653.
8. Shohet RV, Chen S, Zhou YT, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation. 2000;101:2554-2556.
9. Taniyama Y, Tachibana K, Hiraoka K, et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 2002;9:372-380.
10. Christiansen JP, French BA, Klibanov AL, et al. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol. 2003;29:1759-1767.
11. Lu QL, Liang HD, Partridge T, et al. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Ther. 2003;10:396-405.
12. Mukherjee D, Wong J, Griffin B, et al. Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. J Am Coll Cardiol. 2000;35:1678-1686.
13. Song J, Qi M, Kaul S, et al. Stimulation of arteriogenesis in skeletal muscle by microbubble destruction with ultrasound. Circulation. 2002;106:1550-1555.
14. Song J, Cottler PS, Klibanov AL, et al. Microvascular remodeling and accelerated hyperemia blood flow restoration in arterially occluded skeletal muscle exposed to ultrasonic microbubble destruction. Am J Physiol Heart Circ Physiol. 2004;287:H2754-H2761.
15. Chappell JC, Klibanov AL, Price RJ. Ultrasound-microbubble-induced neovascularization in mouse skeletal muscle. Ultrasound Med Biol. 2005;31:1411-1422.
16. Imada T, Tatsumi T, Mori Y, et al. Targeted delivery of bone marrow mononuclear cells by ultrasound destruction of microbubbles induces both angiogenesis and arteriogenesis response. Arterioscler Throm Vasc Biol. 2005;25:2128-2134.
17. Yoshida J, Ohmori K, Takeuchi H, et al. Treatment of ischemic limbs based on local recruitment of vascular endothelial growth factor-producing inflammatory cells with ultrasonic microbubble destruction. J Am Coll Cardiol. 2005;46:899-905.
18. Ay T, Havaux X, Van Camp G, et al. Destruction of contrast microbubbles by ultrasound: effects on myocardial function, coronary perfusion pressure, and microvascular integrity. Circulation. 2001;104:461-466.
19. Miller DL, Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc Natl Acad Sci U S A. 2002;97:10179-10184.
20. Skyba DM, Price RJ, Linka AZ, et al. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation. 1998;98:290-293.
21. Price RJ, Skyba DM, Kaul S, et al. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation. 1998;98:1264-1267.
22. Miller DL, Driscoll EM, Dou C, et al. Microvascular permeabilization and cardiomyocyte injury provoked by myocardial contrast echocardiography in a canine model. J Am Coll Cardiol. 2006;47:1464-1468.
23. Shohet RV, Grayburn PA. Potential bioeffects of ultrasonic destruction of microbubble contrast agents. J Am Coll Cardiol. 2006;7:1469-1470.
24. Miller DL, Li P, Dou C, et al. Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats. Radiology. 2005;237:137-143.
25. Vancraeynest D, Kefer J, Hanet C, et al. Release of cardiac biomarkers during high mechanical index contrast-enhanced echocardiography in humans. Eur Heart J. 2007;28:1236-1241.
26. Song J, Chappell JC, Qi M, et al. Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J Am Coll Cardiol. 2002;39:726-731.
27. Qin S, Ferrara KW. Acoustic response of compliable microvessels containing ultrasound contrast agents. Physics Med Biol. 2006;51:5065-5088.
28. Porter TR, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: demonstration and potential mechanisms. Circulation. 1995;92:2391-2395.
29. Forsberg F, Liu JB, Shi WT, et al. In vivo perfusion estimation using subharmonic contrast microbubble signals. J Ultrasound Med. 2006;25:15-21.
30. Wu J, Nyborg WL. Measurements of frequency spectra of transmission coefficients to ultrasound through trapped microbubbles. Ultrasonics. 1990;28:115-199.
31. Miller DL. Experimental investigation of the response of gas-filled micropores to ultrasound. J Acoust Soc Am. 1982;71:471-476.
32. Tang MX, Eckersley RJ. Frequency and pressure dependent attenuation and scattering by microbubbles. Ultrasound Med Biol. 2007;33:164-168.
33. Marsh JN, Hughes MS, Hall CS, et al. Frequency and concentration dependence of the backscatter coefficient of the ultrasound contrast agent Albunex®. J Acoust Soc Am. 1998;104:1654-1666.
34. Casciaro S, Errico RP, Conversano F, et al. Experimental investigations of nonlinearities and destruction mechanisms of an experimental phospholipid-based ultrasound contrast agent. Invest Radiol. 2007;42:95-104.
35. Everett NB, Simmons B, Lasher EP. Distribution of blood (Fe59) and plasma (I131) volumes of rats determined by liquid nitrogen freezing. Circ Res. 1956;4:419-424.
36. Jakobsen JA, Oyen R, Thomsen HS, et al. Safety of ultrasound contrast agents. Eur Radiol. 2005;15:941-945.
37. Borges AC, Walde T, Reibis RK, et al. Does contrast echocardiography with Optison induce myocardial necrosis in humans? J Am Soc Echocardiogr. 2002;15:1080-1086.
38. Knebel F, Schimke I, Eddicks S, et al. Does contrast echocardiography induce increases in markers of myocardial necrosis, inflammation, and oxidative stress suggesting myocardial injury? Cardiovasc Ultrasound. 2005;3:21.
39. Sahn DJ. Arrhythmias in rat hearts exposed to pulsed ultrasound after intravenous injection of a contrast agent. J Ultrasound Med. 2002;21:1343-1345.
40. Chen S, Shohet RV, Bekeredjian R, et al. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol. 2003;42:301-308.